Thyrocare Technologies Limited (THYROCARE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.238x

Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has a cash flow conversion efficiency ratio of 0.238x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.27 Billion ≈ $13.75 Million USD) by net assets (Rs5.34 Billion ≈ $57.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Thyrocare Technologies Limited - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Thyrocare Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read THYROCARE liabilities breakdown for a breakdown of total debt and financial obligations.

Thyrocare Technologies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Thyrocare Technologies Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Limbach Holdings Inc NASDAQ:LMB	0.144x
Jiangsu Rainbow Heavy Industries Co Ltd SHE:002483	0.014x
Guangdong Mingzhu Group Co Ltd SHG:600382	0.038x
Hektas Ticaret TAS IS:HEKTS	0.024x
Life Healthcare JSE:LHC	0.208x
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	0.000x
GMR Power and Urban Infra Limited NSE:GMRP&UI	0.216x
SHANDONG HI-SP.G.HD-0001 F:HRI	N/A

Annual Cash Flow Conversion Efficiency for Thyrocare Technologies Limited (2011–2025)

The table below shows the annual cash flow conversion efficiency of Thyrocare Technologies Limited from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Thyrocare Technologies Limited market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs5.47 Billion ≈ $59.16 Million	Rs1.91 Billion ≈ $20.69 Million	0.350x	+10.08%
2024-03-31	Rs5.28 Billion ≈ $57.06 Million	Rs1.68 Billion ≈ $18.13 Million	0.318x	+31.50%
2023-03-31	Rs5.35 Billion ≈ $57.88 Million	Rs1.29 Billion ≈ $13.98 Million	0.242x	+12.18%
2022-03-31	Rs5.27 Billion ≈ $56.95 Million	Rs1.13 Billion ≈ $12.26 Million	0.215x	-20.69%
2021-03-31	Rs4.27 Billion ≈ $46.21 Million	Rs1.16 Billion ≈ $12.55 Million	0.272x	-40.60%
2020-03-31	Rs3.67 Billion ≈ $39.65 Million	Rs1.68 Billion ≈ $18.13 Million	0.457x	+98.31%
2019-03-31	Rs4.35 Billion ≈ $47.06 Million	Rs1.00 Billion ≈ $10.85 Million	0.231x	-4.52%
2018-03-31	Rs4.43 Billion ≈ $47.94 Million	Rs1.07 Billion ≈ $11.57 Million	0.241x	+9.81%
2017-03-31	Rs4.07 Billion ≈ $43.99 Million	Rs894.44 Million ≈ $9.67 Million	0.220x	+18.57%
2016-03-31	Rs3.66 Billion ≈ $39.54 Million	Rs678.01 Million ≈ $7.33 Million	0.185x	+67.15%
2015-03-31	Rs3.11 Billion ≈ $33.60 Million	Rs344.68 Million ≈ $3.73 Million	0.111x	-50.51%
2014-03-31	Rs2.06 Billion ≈ $22.31 Million	Rs462.39 Million ≈ $5.00 Million	0.224x	-21.84%
2013-03-31	Rs1.60 Billion ≈ $17.31 Million	Rs459.23 Million ≈ $4.97 Million	0.287x	-28.11%
2012-03-31	Rs1.02 Billion ≈ $11.08 Million	Rs408.87 Million ≈ $4.42 Million	0.399x	-16.85%
2011-03-31	Rs675.33 Million ≈ $7.30 Million	Rs324.07 Million ≈ $3.50 Million	0.480x	--

About Thyrocare Technologies Limited

NSE:THYROCARE India Diagnostics & Research

Market Cap

$837.40 Million

Rs77.43 Billion INR

Market Cap Rank

#10026 Global

#478 in India

Share Price

Rs486.50

Change (1 day)

+3.36%

52-Week Range

Rs349.55 - Rs1591.90

All Time High

Rs1591.90